Research confirms that semaglutide significantly reduces appetite and energy intake, meaning many people on this medication are eating less at any given meal
Survodutide (BI-456906) is an investigational dual agonist targeting: GLP-1 receptors , which regulate appetite, gastric emptying, and glucose metabolism Glucagon receptors , which influence energy expenditure, fat oxidation, and hepatic metabolism Unlike GLP-1only therapies, survodutide is designed to influence both intake and metabolic output
Tested, trusted members of The Vitamin Shoppe family of brands, all products are rigorously tested for purity and potencyso you can be confident in every purchase.
Compounded semaglutide also slows the digestive process, which may help reduce cravings between meals and support lower overall calorie intake as part of a personalized wellness plan
Some are used clinically under supervision for diagnostic or therapeutic applications, and others are frequently used off-label